A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the ...

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

Moderna's COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration (FDA) for use in children ...

Merck has claimed the first-ever FDA approval for an Ebola vaccine, a few weeks after a green light in Europe, as stockpiling efforts build ...

Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best Value Stocks to Buy According to Billionaires. The company announced that ...

Explore last week's key healthcare market trends, top gainers & losers, major deals, Trump's tariff plans, FDA approvals, and significant legal updates.

The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...

BRAVECTO QUANTUM exemplifies Merck Animal Health’s commitment to groundbreaking science and has been recognized as a winner of the 2024 Edison Awards and the 2024 S&P Global Awards for Best New ...

The votes on vaccine recommendations are the first move by the panel after Health and Human Services Secretary Robert F. Kennedy Jr. replaced all its members.

Verona Pharma’s flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease ...